Marcus Skribek

8PUBLICATIONS
17CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 20, 2026
The brain-lung immunotherapy prognostic (BLIP) Score: a novel robust tool for prognostication in non-small cell lung cancer patients with brain metastases.

|Feb 14, 2026
Perioperative immune checkpoint inhibitor therapy across tumors: Insights and shared lessons from a rapidly evolving field.

Karl Björkström, Alexios Matikas, Fernanda Costa Svedman

|Jul 29, 2025
Ex Vivo Drug Sensitivity of Pleural Effusion-Derived Cells from Lung Cancer and Pleural Mesothelioma Patients Is Linked to Clinical Response.

Rita Hutyra-Gram Ötvös, Hanna Krynska, Greta Gudoityte

|Mar 28, 2025
Ex-Vivo Drug-Sensitivity Testing to Predict Clinical Response in Non-Small Cell Lung Cancer and Pleural Mesothelioma: A Systematic Review and Narrative Synthesis.

Jenny Zipprick, Enes Demir, Hanna Krynska

|Oct 28, 2023
Real-world analysis of MET exon 14 mutations in non-small cell lung cancer: a retrospective study from two Swedish hospitals.

Marcus Skribek, Hans Brunnström, Gudrun Oskarsdottir

|Jan 15, 2022
Complications following novel therapies for non-small cell lung cancer.

Marcus Skribek, Konstantinos Rounis, Georgios Tsakonas

Pageof 2

Frequent Collaborators

2 joint publications

Konstantinos Rounis

2 joint publications

Simon Ekman

2 joint publications

Jenny Zipprick

2 joint publications

Hanna Krynska